Docetaxol Plus Cisplatin Versus 5-Fu Plus Cisplatin as 1st-line Chemotherapy in Advanced ESCC Patients

NCT03002064 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

358

Enrollment

OTHER

Sponsor class

Conditions

Esophagus Cancer
Chemotherapy Effects

Interventions

DRUG: Docetaxel
DRUG: Fluorouracil
DRUG: Cisplatin

Sponsor

Sun Yat-sen University